CD4 and rheumatoid arthritis: demonstrated that, although the frequency of peripheral MAIT cells in RA patients was comparable to that in healthy controls, these cells exhibited distinct phenotypic alterations, including markedly reduced CD161 expression and a skewing toward the CD4+ subset (72).